| - GRCh37:
- Chr9:71861709
- GRCh38:
- Chr9:69246793
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71851944
- GRCh38:
- Chr9:69237028
| TJP2 | Q666*, Q668*, Q691*, Q695*, Q722* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71851893
- GRCh38:
- Chr9:69236977
| TJP2 | A649S, A651S, A674S, A678S, A705S | Cholestasis, progressive familial intrahepatic, 4 | Uncertain significance (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71835888
- GRCh38:
- Chr9:69220972
| TJP2 | M120T, M143T, M147T, M174T | Cholestasis, progressive familial intrahepatic, 4, not provided | Uncertain significance (Oct 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71867734
- GRCh38:
- Chr9:69252818
| TJP2 | E1001*, E1072*, E1076*, E1084*, E1086*, E1109*, E1113*, E1140*, E939*, E962*, E966* | not provided, Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 19, 2020) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71869201-71869203
- GRCh38:
- Chr9:69254285-69254287
| TJP2 | E1018del, E1022del, E1057del, E1128del, E1132del, E1140del, E1142del, E1165del, E1169del, E1196del, E995del | Cholestasis, progressive familial intrahepatic, 4 | Uncertain significance (May 18, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71861682-71861683
- GRCh38:
- Chr9:69246766-69246767
| TJP2 | V858fs, V860fs, V883fs, V887fs, V914fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr9:71845071
- GRCh38:
- Chr9:69230155
| TJP2 | G507R, G509R, G532R, G536R, G563R | not provided | Uncertain significance (Dec 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71849315
- GRCh38:
- Chr9:69234399
| TJP2 | | not provided, Cholestasis, progressive familial intrahepatic, 4, Hypercholanemia, familial 1
| Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71852760
- GRCh38:
- Chr9:69237844
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4, not provided, Hypercholanemia, familial 1
| Benign (Sep 10, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71851954
- GRCh38:
- Chr9:69237038
| TJP2 | G669E, G671E, G694E, G698E, G725E | Cholestasis, progressive familial intrahepatic, 4, Hypercholanemia, familial 1, not provided
| Conflicting interpretations of pathogenicity (Nov 23, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:71841038
- GRCh38:
- Chr9:69226122
| TJP2 | Q363fs, Q386fs, Q390fs, Q417fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr9:71855021
- GRCh38:
- Chr9:69240105
| TJP2 | Q819*, Q817*, Q842*, Q846*, Q873* | not provided, Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Apr 7, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71853676
- GRCh38:
- Chr9:69238760
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr9:71831380
- GRCh38:
- Chr9:69216464
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr9:71831253
- GRCh38:
- Chr9:69216337
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71842704
- GRCh38:
- Chr9:69227788
| TJP2 | R389*, R412*, R416*, R443* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Jul 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71852046
- GRCh38:
- Chr9:69237130
| TJP2 | R700*, R702*, R725*, R729*, R756* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71831254
- GRCh38:
- Chr9:69216338
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71852789
- GRCh38:
- Chr9:69237873
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71842762
- GRCh38:
- Chr9:69227846
| TJP2 | S408*, S431*, S435*, S462* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71864318
- GRCh38:
- Chr9:69249402
| TJP2 | R1001*, R945*, R947*, R970*, R974* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71852823
- GRCh38:
- Chr9:69237907
| TJP2 | G712S, G714S, G737S, G741S, G768S | Cholestasis, progressive familial intrahepatic, 4, Melnick-Fraser syndrome | Pathogenic/Likely pathogenic (Apr 12, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71849354
- GRCh38:
- Chr9:69234438
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71845051
- GRCh38:
- Chr9:69230135
| TJP2 | L500S, L502S, L525S, L529S, L556S | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71831376
- GRCh38:
- Chr9:69216460
| TJP2 | L110R, L56R, L79R, L83R | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic (Oct 15, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71840267
- GRCh38:
- Chr9:69225351
| TJP2 | R334*, R311*, R338*, R365* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Sep 24, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr9:71851057
- GRCh38:
- Chr9:69236141
| TJP2 | R632*, R609*, R607*, R663*, R636* | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Dec 26, 2019) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71845053
- GRCh38:
- Chr9:69230137
| TJP2 | A526S, A503S, A530S, A557S, A501S | Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4, not provided
| Uncertain significance (Sep 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71867801
- GRCh38:
- Chr9:69252885
| TJP2 | T1131M, T1162M, T1023M, T1094M, T1135M, T961M, T984M, T988M, T1098M, T1106M, T1108M | not provided, Cholestasis, progressive familial intrahepatic, 4, Hypercholanemia, familial 1
| Uncertain significance (Feb 24, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71845108
- GRCh38:
- Chr9:69230192
| TJP2 | A544V, A521V, A575V, A519V, A548V | Cholestasis, progressive familial intrahepatic, 4, Hypercholanemia, familial 1, not provided
| Uncertain significance (Jan 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71840325
- GRCh38:
- Chr9:69225409
| TJP2 | | not provided, Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4
| Likely pathogenic (Jul 14, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71836270-71836271
- GRCh38:
- Chr9:69221354-69221355
| TJP2 | A250fs, A273fs, A277fs, A304fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Nov 6, 2013) | no assertion criteria provided |
| - GRCh37:
- Chr9:71833276-71861605
- GRCh38:
- Chr9:69218360-69246689
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Jul 12, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71841091
- GRCh38:
- Chr9:69226175
| TJP2 | D404N, D408N, D381N, D435N | Cholestasis, progressive familial intrahepatic, 4 | Likely pathogenic (Jul 12, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71842710
- GRCh38:
- Chr9:69227794
| TJP2 | S392fs, S446fs, S419fs, S415fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Jul 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr9:71867780
- GRCh38:
- Chr9:69252864
| TJP2 | T1124M, T1099M, T1128M, T1091M, T981M, T1016M, T1087M, T1101M, T954M, T1155M, T977M | not provided, Hypercholanemia, familial 1 | Conflicting interpretations of pathogenicity (May 4, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:71863051
- GRCh38:
- Chr9:69248135
| TJP2 | A931T, A906T, A935T, A908T, A962T | Cholestasis, progressive familial intrahepatic, 4, Hypercholanemia, familial 1, not provided, Inborn genetic diseases | Uncertain significance (Apr 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71866027
- GRCh38:
- Chr9:69251111
| TJP2 | A1023V, A1054V, A915V, A1027V, A986V, A998V, A1000V, A990V | not provided, Cholestasis, progressive familial intrahepatic, 4 | Conflicting interpretations of pathogenicity (Nov 17, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:71836028-71836029
- GRCh38:
- Chr9:69221112-69221113
| TJP2 | S192fs, S223fs, S169fs, S196fs | not provided | Pathogenic (Aug 31, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71865932
- GRCh38:
- Chr9:69251016
| TJP2 | | not specified, Cholestasis, progressive familial intrahepatic, 4, not provided, Hypercholanemia, familial 1 | Benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71836274
- GRCh38:
- Chr9:69221358
| TJP2 | A250fs, A277fs, A304fs, A273fs | not provided | Pathogenic (Aug 8, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71854928-71854929
- GRCh38:
- Chr9:69240012-69240013
| TJP2 | N789fs, N814fs, N791fs, N845fs, N818fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Dec 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr9:71862927
- GRCh38:
- Chr9:69248011
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Dec 1, 2015) | no assertion criteria provided |
| - GRCh37:
- Chr9:71869122-71869287
- GRCh38:
- Chr9:69254206-69254371
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (May 19, 2015) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71831398
- GRCh38:
- Chr9:69216482
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4, not provided, not specified, Hypercholanemia, familial 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71867819
- GRCh38:
- Chr9:69252903
| TJP2 | | Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4, not specified
| Likely benign (Sep 2, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71842682-71842684
- GRCh38:
- Chr9:69227766-69227768
| TJP2 | I382del, I405del, I409del, I436del | Nonsyndromic Hearing Loss, Dominant, Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4, not specified, not provided | Uncertain significance (Jul 15, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71842728
- GRCh38:
- Chr9:69227812
| TJP2 | R397C, R420C, R451C, R424C | Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4, not specified, not provided | Uncertain significance (Apr 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71869274
- GRCh38:
- Chr9:69254358
| TJP2 | R1016Q, R1186Q, R1039Q, R1149Q, R1161Q, R1190Q, R1153Q, R1217Q, R1043Q, R1078Q, R1163Q | Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4, not specified
| Uncertain significance (Jan 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71831325
- GRCh38:
- Chr9:69216409
| TJP2 | T39M, T62M, T66M, T93M | not specified, not provided | Conflicting interpretations of pathogenicity (Sep 27, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:71851863
- GRCh38:
- Chr9:69236947
| TJP2 | | not provided | Pathogenic (Oct 22, 2014) | criteria provided, single submitter |
| - GRCh37:
- Chr9:71842938
- GRCh38:
- Chr9:69228022
| TJP2 | A454fs, A458fs, A485fs, A431fs, A429fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Apr 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr9:71836342
- GRCh38:
- Chr9:69221426
| TJP2 | S273fs, S296fs, S300fs, S327fs | Cholestasis, progressive familial intrahepatic, 4 | Pathogenic (Apr 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr9:71836226-71836229
- GRCh38:
- Chr9:69221310-69221313
| TJP2 | A260fs, A287fs, A233fs, A256fs | not provided | Pathogenic (Dec 28, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71865943
- GRCh38:
- Chr9:69251027
| TJP2 | | not specified, not provided, Hypercholanemia, familial 1, Cholestasis, progressive familial intrahepatic, 4 | Benign/Likely benign (Oct 10, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71862987
- GRCh38:
- Chr9:69248071
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4, not specified, not provided, Hypercholanemia, familial 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71862975
- GRCh38:
- Chr9:69248059
| TJP2 | | Cholestasis, progressive familial intrahepatic, 4, not specified, not provided, Hypercholanemia, familial 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:71843023
- GRCh38:
- Chr9:69228107
| TJP2 | D482E, D459E, D513E, D457E, D486E | Cholestasis, progressive familial intrahepatic, 4, not specified, not provided, Hypercholanemia, familial 1 | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |